This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Pharmacopeia Drug Discovery, Inc.. Active years: 2005-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edison, NJ (US) (2005 - 2010)
- Hillsborough, NJ (US) (2020 - 2023)
Company Filing History:
4 out of 3,745 
1 out of 52 Years Active: 2005-2023
Title: The Innovative Path of Inventor Peng Geng
Introduction:
Inventor Peng Geng, based in Hillsborough, NJ, is a prolific inventor with a total of 5 patents to his name. His groundbreaking work in pharmaceutical compounds has left a mark on the industry, with his latest patents showcasing his expertise in synthesizing complex molecules.
Latest Patents:
Among his latest patents is a process for preparing tetrahydrocarbazole carboxamide compound, which involves the reaction of specific compounds in the presence of a base. Additionally, Peng Geng has disclosed a process for preparing indole carboxamide compounds, demonstrating his mastery in creating intricate chemical structures.
Career Highlights:
Peng Geng has made significant contributions to the field of pharmaceuticals through his work at renowned companies such as Bristol-Myers Squibb and Pharmacopeia Drug Discovery, Inc. His role in developing novel compounds has been instrumental in advancing drug discovery and development.
Collaborations:
Throughout his career, Peng Geng has collaborated with esteemed professionals in the industry, including coworkers Ronald Carrasquillo and Eric C. Huang. Together, they have driven innovation and pushed the boundaries of pharmaceutical research.
Conclusion:
In conclusion, Peng Geng's dedication to innovation and his ability to unravel the complexities of chemical synthesis have positioned him as a leading figure in the field of pharmaceutical inventions. His patents and career achievements stand as a testament to his contribution to the advancement of science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile